Share on StockTwits

Cardinal Health (NYSE:CAH)‘s stock had its “overweight” rating reaffirmed by investment analysts at Barclays in a note issued to investors on Tuesday. They currently have a $82.00 target price on the stock, up from their previous target price of $77.00. Barclays’ target price points to a potential upside of 16.68% from the company’s current price.

In other Cardinal Health news, CAO Stuart G. Laws unloaded 21,266 shares of Cardinal Health stock on the open market in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $72.50, for a total transaction of $1,541,785.00. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of Cardinal Health (NYSE:CAH) traded up 0.80% during mid-day trading on Tuesday, hitting $70.84. The stock had a trading volume of 1,430,108 shares. Cardinal Health has a 1-year low of $49.65 and a 1-year high of $74.40. The stock’s 50-day moving average is $70.29 and its 200-day moving average is $69.28. The company has a market cap of $24.100 billion and a price-to-earnings ratio of 70.28.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.

A number of other firms have also recently commented on CAH. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday. They now have a $80.00 price target on the stock, up previously from $76.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday. They now have a $74.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Cardinal Health from $78.00 to $84.00 in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $78.03.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.